KYMR

NASDAQStock

Kymera Therapeutics, Inc.

$78.44-3.10 (-3.80%)

52-Week Range

$21.05
$95.03

Key Stats

Market Cap

6.4B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.30

Volume

398.1K

Avg Volume

873.3K

Performance

1M

-2.50%

3M

-13.58%

6M

+63.92%

YTD

+6.51%

1Y

+120.80%

3Y

+148.32%

5Y

+29.08%

Price Chart

ETF Exposure

KYMR is held by 95 ETFs

ETFFund NameWeight
VXFVanguard Extended Market ETF0.06%
VHTVanguard Health Care ETF0.05%
VFMOVanguard U.S. Momentum Factor ETF0.05%
WSMLiShares MSCI World Small-Cap ETF0.04%
SMMDiShares Russell 2500 ETF0.04%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.04%
HDGProShares - Hedge Replication ETF0.02%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.02%
DFACDimensional - US Core Equity 2 ETF0.02%
DXUVDimensional - US Vector Equity ETF0.02%
DCORDimensional - US Core Equity 1 ETF0.01%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.01%
DFAUDimensional - US Core Equity Market ETF0.01%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.01%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.01%
SCHBSchwab U.S. Broad Market ETF0.01%
ESGVVanguard ESG U.S. Stock ETF0.01%
IWViShares Russell 3000 ETF0.01%
VTIVanguard Total Stock Market ETF0.01%
VTHRVanguard Russell 3000 ETF0.01%
DFUSDimensional - US Equity Market ETF0.00%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.00%
VTVanguard Total World Stock ETF0.00%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
AVLCAvantis U.S. Large Cap Equity ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About KYMR ETF Exposure

Kymera Therapeutics, Inc. (KYMR) is held by 95 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.4B, KYMR is a widely held institutional stock. The stock currently trades at $78.44. Investors can gain exposure to KYMR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold KYMR, sorted by portfolio weight.